PDSB P/E Ratio
P/E Ratio as of Jun 13, 2025: -1.87
Average-1.66
Median-1.67
Minimum-1.91
Maximum-1.44
-1.87
Past Month-0.47 (33.57%)
The P/E ratio for PDSB is -1.87 as of Jun 13, 2025. This represents a decrease of -1.06% compared to its 12-month average P/E ratio of -1.89. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
PDS Biotechnology Corporation P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
PDS Biotechnology Corporation’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing PDS Biotechnology Corporation to industry peers.
PDS Biotechnology Corporation P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
PDS Biotechnology Corporation’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing PDS Biotechnology Corporation to industry peers.
PDSB P/E Ratio Insights
See PDS Biotechnology Corporation’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in PDSB
Order type
Buy in
Order amount
Est. shares
0 shares
PDSB P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 2, 2025 | $1.41 | -1.50 |
| May 1, 2025 | $1.33 | -1.29 |
| Apr 1, 2025 | $1.08 | -1.05 |
| Mar 3, 2025 | $1.21 | -1.04 |
| Feb 3, 2025 | $1.59 | -1.36 |
| Jan 2, 2025 | $1.73 | -1.48 |
PDSB End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -1.87 | +33.57% |
| 2024 | -1.40 | -51.89% |
| 2023 | -2.91 | -77.70% |
| 2022 | -13.05 | +1.40% |
| 2021 | -12.87 | +479.73% |
| 2020 | -2.22 | — |
FAQs About PDS Biotechnology Corporation (PDSB) P/E ratio
The latest P/E ratio of PDSB is -1.87, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
PDS Biotechnology Corporation’s last 12-month average P/E ratio is -1.89, compared to its current P/E ratio of -1.87. This reflects a decrease of -1.06%.
PDS Biotechnology Corporation’s current P/E ratio of -1.87 is lower than its last 12-month average P/E of -1.89. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
PDS Biotechnology Corporation’s average P/E ratio over the last 3 years is -3.49. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
PDS Biotechnology Corporation’s average P/E ratio over the last 5 years is -5.94. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.